We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$169M
AUM Growth
-$69.7M
(-29%)
Cap. Flow
-$68M
Cap. Flow
% of AUM
-40.18%
Top 10 Holdings %
Top 10 Hldgs %
42.32%
Holding
107
New
38
Increased
7
Reduced
15
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$5.66M |
| 2 |
Edwards Lifesciences
EW
|
+$3.26M |
| 3 |
SIEN
Sientra, Inc.
SIEN
|
+$3.25M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3M |
| 5 |
Qiagen
QGEN
|
+$2.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dentsply Sirona
XRAY
|
+$6.09M |
| 2 |
HCA Healthcare
HCA
|
+$3.95M |
| 3 |
Boston Scientific
BSX
|
+$3.87M |
| 4 |
HOLX
Hologic
HOLX
|
+$3.85M |
| 5 |
ATHN
Athenahealth, Inc.
ATHN
|
+$3.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 51.93% |
| 2 | Industrials | 2.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
| $13M | 7.69% |
160,000
+60,000
| +60% | +$5.11M |
|
|
2
CALL
Merck
MRK
$316B
| $10.9M | 6.44% |
+209,600
| New | +$11.3M |
|
3
ICU Medical
ICUI
$4.3B
| $7.07M | 4.17% |
28,000
-7,000
| -20% | -$1.65M |
|
4
Globus Medical
GMED
$11.1B
| $6.73M | 3.97% |
135,000
-47,500
| -26% | -$2.23M |
|
5
LivaNova
LIVN
$4.69B
| $6.38M | 3.77% |
72,100
-17,900
| -20% | -$1.52M |
|
6
CALL
Bristol-Myers Squibb
BMY
$135B
| $6.33M | 3.74% |
+100,000
| New | +$6.43M |
|
7
CALL
Cigna
CI
$72.4B
| $5.87M | 3.47% |
+35,000
| New | +$6.8M |
|
|
8
Merck
MRK
$316B
| $5.45M | 3.22% |
+104,800
| New | +$5.66M |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals
ALXN
| $5.02M | 2.96% |
45,000
+25,100
| +126% | +$3M |
|
10
Baxter International
BAX
$14.7B
| $4.88M | 2.88% |
75,000
+5,000
| +7% | +$338K |
|
|
SIEN
11
CALL
DELISTED
Sientra, Inc.
SIEN
| $4.87M | 2.87% |
+50,360
| New | +$5.56M |
|
|
IVC
12
DELISTED
Invacare Corporation
IVC
| $4.82M | 2.85% |
276,796
-478
| -0.2% | -$8.43K |
|
|
XENT
13
DELISTED
Intersect ENT, Inc
XENT
| $4.32M | 2.55% |
110,000
+10,000
| +10% | +$365K |
|
14
PUT
Incyte
INCY
$24.4B
| $4.17M | 2.46% |
50,000
| – | – |
|
15
Abbott
ABT
$182B
| $3.63M | 2.14% |
60,500
-19,500
| -24% | -$1.17M |
|
|
ATHN
16
DELISTED
Athenahealth, Inc.
ATHN
| $3.58M | 2.11% |
25,000
-25,000
| -50% | -$3.42M |
|
17
BioMarin Pharmaceuticals
BMRN
$11.7B
| $3.54M | 2.09% |
43,700
| – | – |
|
|
18
Edwards Lifesciences
EW
$51.6B
| $3.49M | 2.06% |
+75,000
| New | +$3.26M |
|
19
Medtronic
MDT
$110B
| $3.41M | 2.01% |
42,500
+5,000
| +13% | +$412K |
|
|
ALXN
20
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
| $3.34M | 1.98% |
+30,000
| New | +$3.59M |
|
|
SIEN
21
DELISTED
Sientra, Inc.
SIEN
| $2.84M | 1.68% |
+29,417
| New | +$3.25M |
|
22
DexCom
DXCM
$32.8B
| $2.75M | 1.63% |
+148,560
| New | +$2.2M |
|
|
VRAY
23
DELISTED
ViewRay, Inc.
VRAY
| $2.71M | 1.6% |
422,000
+60,000
| +17% | +$500K |
|
|
24
Qiagen
QGEN
$8.73B
| $2.42M | 1.43% |
+70,729
| New | +$2.48M |
|
|
25
Boston Scientific
BSX
$71.1B
| $2.39M | 1.41% |
87,500
-142,500
| -62% | -$3.87M |
|
Similar funds
GMP
BCA
ONGA
RC
DOFI
SR
TC
PA
Pura Vida Investments's Q1 2018 Portfolio in Review
As of Q1 2018, Pura Vida Investments held 107 positions worth $169M, down 29% from $239M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Pura Vida Investments withdrew a net $68M in Q1 2018, closing 41 positions and reducing 15 holdings. Its most notable exit was Dentsply Sirona, an estimated $6.09M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 46% a quarter earlier, followed by Industrials.
Against the trend, Pura Vida Investments opened a new position in Merck worth $5.45M.
- Pura Vida Investments's largest Q1 2018 buy was Merck: 104,800 shares worth $5.45M.
- Pura Vida Investments added most to Alexion Pharmaceuticals in Q1 2018, an estimated $3M increase.
- Pura Vida Investments's biggest Q1 2018 reduction was Boston Scientific, cutting an estimated $3.87M.
- Pura Vida Investments fully exited Dentsply Sirona in Q1 2018, selling an estimated $6.09M.
- Pura Vida Investments's ten largest holdings make up 42% of its $169M portfolio in Q1 2018.
- Pura Vida Investments opened 38 new positions and closed 41 in Q1 2018.
- Pura Vida Investments's portfolio value fell 29% quarter-over-quarter to $169M.
Based on Pura Vida Investments's 13F filing for Q1 2018, filed 14 May 2018.